BioCentury
ARTICLE | Clinical News

Betafectin PGG-glucan: FDA completed its review of ABTI's protocol for Phase III testing of safety and efficacy of two doses as compared to placebo; the primary

January 3, 1995 8:00 AM UTC

Alpha-Beta Technology Inc. (ABTI), Worcester, Mass. Product: Betafectin PGG-glucan, engineered carbohydrate polymer Indication: Prevent infection after major gastrointestinal surgery Status: FDA comp...